Best shares to buy today
• Sanofi: Buy above £5,980 and drops to £5,850, stop £5,800, target £6,500-6,750
• Asterdm: Buy above £477, stop £465, target £520-540
• Balramchin: Buy CMP and on dips to £520, stop £515, target £580-600
Stock market on April 7
On April 7, Dalal Street saw a dramatic recession because widespread panic sales caused a steep fall in market valuations. An amazing £16 Lakh Crore in market value was wiped out-the most important intraday-in-departure since June 2024 transferred by the rate-related actions of Donald Trump who also shake Wall Street.
Worldwide fears to escalate trade tensions and the possibility of a full recession of Nerzende Investors. Inflation problems, falling consumption and imminent economic instability reinforced the sale. The prospect of retribution rates from countries such as China and Canada, as well as the European Union, has further fueled the uncertainty, so that the markets were informed.
Also read: Bharat Forge on the edge, because the trading pact of India-us has the key to tariff lighting
Among the handy shares were registered by Trent, Tata Steel, JSW Steel, Hindalco Industries, Shriram Finance and L&T, while Hindustan Unilever was the only win.
All sectoral indices ended the session in a negative area. The metal index led the losses with a steep fall of 6.7%, followed by a decrease of 5.6% in the realty index. Other sectors such as media, PSU bank, car, energy and it also saw considerable losses, fell between 2.5% and 4%. The widespread sale emphasized the vulnerability of the market for global economic uncertainties and the possible consequences of trade conflicts.
Outlook for Trade
With the RBI policy together with the Q4 results, the Bearish Momentum can create some unbridled volatility. Worldwide markets now play an important role in the way things will take place. However, the road that lies in front of us seems full of tension, without clear signals that can cause a revival. Currently, the limited rise in Nifty Bank has left a few questions unanswered. As we said on Friday, evidence of a revival is seen in Nifty, while a muted scenario is observed in Nifty Bank, because it has again denied the hard work that was done last week. Vibes remain muted, but with a hesitant drift to the positive side.
Read also | FMCG’s Q4 -why the giants of the consumer goods of India expect a boring quarter
Publishing data shows that higher levels are under pressure. Persistent sale at higher levels continues to prove that the maximum pain in Nifty Bank at 51,000 and Nifty at 22,750. This suggests that the trends have strong steel winds. The reaction of lower levels yesterday and the end above 23,000, which forms a hammer pattern, emphasizes that the levels slowly and steadily cause more bullishness in the market. The markets act with a light bullish bias while we will go into Tuesday.
View the full image
Three shares to buy today, recommended by Neotrader’s Raja Venkatraman
Sanofi: Buy above £5,980 and drops to £5,850, stop £5,800 target £6,500-6,750
Koop: Sanofi (current price: £5,972,35)
- Why it is recommended: Positive traction has been seen in recent weeks in selected pharmaceutical shares. The increase in the positive directional index clearly indicates that the trends can continue to exist in the coming days.
- Main statistics: P/e: 44, 52 weeks high: £10,525, volume: 15.66k
- Technical analysis: Support £5.540, resistance to £6,500
- Risk factors: Dependence on global supply chains for raw materials and production can pose risks during disruptions
- Buy at: £5,980 and drops to £5,850
- Target price: £6,500-6,750 in three months
- Stop loss: £5,800
Also read: Resting markets brace brace due to the impact of Trump’s rate Toorn this profit season
Asterdm: Buy above £477, stop £465; goal £520-540
Buy: Asterdm (current price: £475.80)
- Why it is recommended: After a disappointing 2025, the prices of lower levels were revived with a real purchase to generate upward traction. Now that the stock at lower levels, we see another steady purchase interest rates.
- Main statistics: P/e: 3.5, 52 weeks high: £558, volume: 1.32 m
- Technical analysis: Support £400, resistance to £520
- Risk factors: In several countries, the company is exposed to various health care rules and compliance risks.
- Buy at: £477
- Target price: £520-540 in 3 months
- Stop loss: £465
Balramchin: Buy CMP and on dips to £520, stop £515, target £580-600
Koop: Balramchin (current price: £536.10)
- Why it is recommended:A strong series of support now makes a recovery possible. As buying interest at lower levels came forward and the market that an upward mind shows, we can consider a long chance.
- Main statistics: P/e: 27, 52 weeks high: £692, Volume: 316.16K
- Technical analysis: Support £431, resistance to £610
- Risk factors: Fluctuations in domestic and international sugar prices can significantly influence sales.
- Buy at: Cmp and drops to £520
- Target price: £580-600 in 3 months
- Stop loss: £515
Raja Venkatraman is co-founder, Neo-Trader. His SEBI registered research analyst registration no. Is inh000016223.
Investments in effects are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and Nisme certification in no way guarantees the performance of the intermediary or offers any security of returns to investors.
Disclaimer: The views and recommendations in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before we make investment decisions.
